Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.
There are no as such competitors for PharmaCyte Biotech.
There is no analysis for PharmaCyte Biotech to provide a consensus price target.
The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $0.714 last updated June 10, 2026 at 4:44 PM EDT.
There are no upcoming dividends for PharmaCyte Biotech.
PharmaCyte Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for PharmaCyte Biotech.
PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.